Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared a post by ASCO on LinkedIn, adding:
“Grateful and humbled to share that I’ve been selected for the Leadership Development Program at the American Society of Clinical Oncology (ASCO)!
This one feels personal.
My journey with ASCO started in 2014 when I was a resident, trying to find my footing in oncology. Over time, ASCO became much more than a professional home-it’s been a space for continuous learning, meaningful connections, and growth. From educational initiatives to advocacy efforts, from being a mentee to stepping into mentorship roles, each experience has shaped how I think about cancer care, research, and leadership.
I’m especially grateful to Manmeet Ahluwalia for his constant support and belief in me. And a sincere thank you to Renuka Iyer, Cathy Eng, and Namrata (Neena) Vijayvergia, for their thoughtful feedback and encouragement throughout the application process-it truly made a difference.
What excites me most is the opportunity to learn alongside an exceptional group of colleagues and mentors and to continue growing within a community that has already given me so much. As I move forward, I’m looking forward to bringing these perspectives back to Miami Cancer Institute, Baptist Health, and continuing to expand this work both locally and globally in alignment with ASCO’s mission to improve the lives of patients with cancer.
Looking forward to what lies ahead-and to paying it forward!”
Quoting ASCO‘s post:
“Congratulations to the 2026-2027 Leadership Development Program (LDP) and LDP: Education Scholars participants!
Through a competitive application process, these ASCO members were selected to engage in a highly interactive, year-long program where they will hone advanced leadership skills.
The LDP participants will also gain exposure to the roles and mission of ASCO, while LDP: Education Scholars will explore evidence-based education.
Interested in learning more and participating in a future program?
Visit and look out for 2027-2028 applications opening this summer.”
Other articles featuring Sarbajit Mukherjee on OncoDaily.
